12 independently checked trend briefs about this subject, newest first.
headlinez.news detected 12 source-qualified news clusters connected to Alzheimer’s Disease between June 23, 2026 and July 15, 2026. They span 3 newsroom categories and average 9.4 independent sources per brief.
This hub includes only briefs supported by at least four sources and passed by the site's verification gate. Raw or weak detections may exist but are excluded here. Topic matching is based on the entities and themes recorded with each brief; open a card to inspect its source links, publication time, verification label and velocity history. Read the methodology and editorial policy for the full rules.
New clinical studies suggest blood-based testing can identify Alzheimer’s disease risk in healthy adults up to a decade before symptom onset.
Researchers are investigating a human-safe drug candidate that shows potential in repairing DNA damage associated with Alzheimer’s disease in mice.
Biogen’s tau-targeting Alzheimer’s drug shows early promise in slowing cognitive decline, sparking fresh debate in dementia research
Researchers identify potential blood-based biomarkers that could detect dementia risk *decades* before symptoms emerge
New research suggests alcohol consumption affects brain plasticity and Alzheimer's-related circuits differently depending on underlying brain pathology.
BCG vaccine linked to unexpected shifts in brain immunity and Alzheimer’s biomarkers—raising questions about its potential role in neurodegeneration.
New reports identify four potential early warning signs of dementia that may emerge before memory loss.
Actor and activist Danny Glover has publicly revealed a diagnosis of Alzheimer’s disease as he approaches his 80th birthday.
A single blood protein could redefine Alzheimer’s detection—decades before symptoms appear.
New research suggests high-dose DHA omega-3 supplements do not effectively prevent memory decline or reduce the risk of Alzheimer's disease.
Scientists identify tubulin protein as a potential blocker of toxic brain clumps in Alzheimer’s and Parkinson’s
Widely used glucosamine supplements now under scrutiny for potential link to accelerated Alzheimer’s progression